Skip to main content
SpringerLink
Log in

HIV and Injection Drug Use: New Approaches to HIV Prevention

  • Chapter
  • First Online:
Global Virology III: Virology in the 21st Century

  • 1010 Accesses

Abstract

Injection drug use has become a major public health problem. Its emerging significance is demonstrated globally in the dual HIV and HCV epidemics among people who inject drugs (PWID). Despite the advent of effective antivirals against HIV and HCV, PWID face multiple barriers to access and adherence to such treatments. Additionally, the lack of infrastructure for medication-assisted therapy for opioid addiction, inadequate treatment for underlying mental health disorders, and poor access to needle-syringe exchange programs and HIV pre-exposure prophylaxis pose grave challenges to control these epidemics. In this chapter, we focus on the impact of the global injection drug use epidemic as well as new approaches on HIV prevention and the HIV care continuum for people who inject drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization (WHO). HIV/AIDS. https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Published 2018. Updated July 19, 2018. Accessed 15 Apr 2019.

  2. Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.

    Article  PubMed  PubMed Central  Google Scholar 

  3. World Health Organization (WHO). HIV/AIDS: People who inject drugs. https://www.who.int/hiv/topics/idu/en/. Published 2019. Accessed 15 Apr 2019.

  4. Shapshak P, Kangueane P, Fujimura RK, et al. Editorial neuroAIDS review. AIDS (London, England). 2011;25(2):123–41.

    Article  Google Scholar 

  5. Tyagi M, Bukrinsky M, Simon GL. Mechanisms of HIV transcriptional regulation by drugs of abuse. Curr HIV Res. 2016;14(5):442–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tyagi M, Weber J, Bukrinsky M, Simon GL. The effects of cocaine on HIV transcription. J Neurovirol. 2016;22(3):261–74.

    Article  CAS  PubMed  Google Scholar 

  7. Csete J, Kamarulzaman A, Kazatchkine M, et al. Public health and international drug policy. Lancet (London, England). 2016;387(10026):1427–80.

    Article  Google Scholar 

  8. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiat. 2014;71(7):821–6.

    Article  Google Scholar 

  9. Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016;160:127–34.

    Article  PubMed  PubMed Central  Google Scholar 

  10. National Institute on Drug Abuse. Opioid overdose crisis. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis#nine. Published 2019. Updated January 2019. Accessed 15 Apr 2019.

  11. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Joint United Nations Programme on HIV/AIDS (UNAIDS). Miles to go. Closing gaps, breaking barriers, righting injustices. 2018. https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf. Accessed 16 Apr 2019.

  13. Campbell EM, Jia H, Shankar A, et al. Detailed transmission network analysis of a large opiate-driven outbreak of HIV infection in the United States. J Infect Dis. 2017;216(9):1053–62.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.

    Article  CAS  PubMed  Google Scholar 

  15. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis. Geneva: World Health Organization.

    Google Scholar 

  16. Joint United Nations Programme on HIV/AIDS (UNAIDS). Fast-track: ending the AIDS epidemic by 2030. 2014. https://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf. Accessed 18 Apr 2019.

  17. Centers for Disease Control (CDC). HIV among people who inject drugs. https://www.cdc.gov/hiv/group/hiv-idu.html. Published 2019. Updated March 15, 2019. Accessed 18 Apr 2019.

  18. Escudero DJ, Lurie MN, Mayer KH, et al. The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study. BMC Public Health. 2017;17(1):614.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Metsch L, Philbin MM, Parish C, Shiu K, Frimpong JA, Giangle M. HIV testing, care, and treatment among women who use drugs from a global perspective: progress and challenges. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S162–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Miller WC, Hoffman IF, Hanscom BS, et al. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet (London, England). 2018;392(10149):747–59.

    Article  Google Scholar 

  21. Bachireddy C, Weisberg DF, Altice FL. Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission. Addiction. 2015;110(12):1869–71.

    Article  PubMed  Google Scholar 

  22. Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altice FL. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia. Am J Drug Alcohol Abuse. 2008;34(4):511–7.

    Article  PubMed  Google Scholar 

  23. Degenhardt LMB, Wirtz AL, Wolfe D, Kamarulzaman A, Carrieri MP, Strathdee SAM-SK, Kazatchkine M, Beyrer C. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy. 2014;25(1):8.

    Article  Google Scholar 

  24. Larney S, Peacock A, Leung J, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5(12):e1208–20.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Smith MK, Graham M, Latkin CA, Go VL. Using contact patterns to inform HIV interventions in persons who inject drugs in Northern Vietnam. J Acquir Immune Defic Syndr. 2018;78(1):1–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tempalski B, Cooper HLF, Kelley ME, et al. Identifying which place characteristics are associated with the odds of recent HIV testing in a large sample of people who inject drugs in 19 US metropolitan areas. AIDS Behav. 2019;23(2):318–35.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28:850–857.e9.

    Article  PubMed  Google Scholar 

  28. Roth A, Tran N, Piecara B, Welles S, Shinefeld J, Brady K. Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: national HIV behavioral surveillance, 2015. AIDS Behav. 2019;23(7):1833–40.

    Article  PubMed  Google Scholar 

  29. Bednasz CJ, Venuto CS, Ma Q, Morse GD. Pharmacokinetic considerations for combining antiretroviral therapy, direct-acting antiviral agents for hepatitis C virus, and addiction treatment medications. Clin Pharmacol Drug Dev. 2017;6(2):135–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Clarke TK, Crist RC, Ang A, et al. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. Pharmacogenomics J. 2014;14(3):303–8.

    Article  CAS  PubMed  Google Scholar 

  31. Nasarruddin AM, Saifi RA, Othman S, Kamarulzaman A. Opening up the HIV epidemic: a review of HIV seropositive status disclosure among people who inject drugs. AIDS Care. 2017;29(5):533–40.

    Article  PubMed  Google Scholar 

  32. Thomson N, Moore T, Crofts N. Assessing the impact of harm reduction programs on law enforcement in Southeast Asia: a description of a regional research methodology. Harm Reduct J. 2012;9:23.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Altice FL, Azbel L, Stone J, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet (London, England). 2016;388(10050):1228–48.

    Article  Google Scholar 

  34. Muessig KE, Nekkanti M, Bauermeister J, Bull S, Hightow-Weidman LB. A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care. Curr HIV/AIDS Rep. 2015;12(1):173–90.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Guse K, Levine D, Martins S, et al. Interventions using new digital media to improve adolescent sexual health: a systematic review. J Adolesc Health. 2012;51(6):535–43.

    Article  PubMed  Google Scholar 

  36. International Telecommunication Union (ITU). ICT facts and figures 2017. 2017. https://www.itu.int/en/ITU-D/Statistics/Documents/facts/ICTFactsFigures2017.pdf. Accessed 19 Apr 2019.

  37. Taggart T, Grewe ME, Conserve DF, Gliwa C, Roman Isler M. Social media and HIV: a systematic review of uses of social media in HIV communication. J Med Internet Res. 2015;17(11):e248.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Latkin CA, Davey-Rothwell MA, Knowlton AR, Alexander KA, Williams CT, Boodram B. Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr (1999). 2013;63(Suppl 1):S54–8.

    Article  Google Scholar 

  39. Bull SS, Levine DK, Black SR, Schmiege SJ, Santelli J. Social media-delivered sexual health intervention: a cluster randomized controlled trial. Am J Prev Med. 2012;43(5):467–74.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lelutiu-Weinberger C, Pachankis JE, Gamarel KE, Surace A, Golub SA, Parsons JT. Feasibility, acceptability, and preliminary efficacy of a live-chat social media intervention to reduce HIV risk among Young men who have sex with men. AIDS Behav. 2015;19(7):1214–27.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Tso LS, Tang W, Li H, Yan HY, Tucker JD. Social media interventions to prevent HIV: a review of interventions and methodological considerations. Curr Opin Psychol. 2016;9:6–10.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Jaganath D, Gill HK, Cohen AC, Young SD. Harnessing Online Peer Education (HOPE): integrating C-POL and social media to train peer leaders in HIV prevention. AIDS Care. 2012;24(5):593–600.

    Article  PubMed  Google Scholar 

  43. Brenner BG, Ibanescu RI, Hardy I, Roger M. Genotypic and phylogenetic insights on prevention of the spread of HIV-1 and drug resistance in “real-world” settings. Viruses. 2017;10(1):10.

    Article  PubMed Central  CAS  Google Scholar 

  44. Bisaso KR, Anguzu GT, Karungi SA, Kiragga A, Castelnuovo B. A survey of machine learning applications in HIV clinical research and care. Comput Biol Med. 2017;91:366–71.

    Article  PubMed  Google Scholar 

  45. Singh Y, Mars NNM. Applying machine learning to predict patient-specific current CD 4 cell count in order to determine the progression of human immunodeficiency virus (HIV) infection. Afr J Biotechnol. 2013;12(23):11.

    Google Scholar 

  46. Larder B, Wang D, Revell A. Application of artificial neural networks for decision support in medicine. Methods Mol Biol (Clifton, NJ). 2008;458:123–36.

    Google Scholar 

  47. Li Y, Rapkin B. Classification and regression tree uncovered hierarchy of psychosocial determinants underlying quality-of-life response shift in HIV/AIDS. J Clin Epidemiol. 2009;62(11):1138–47.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Munoz-Moreno JA, Perez-Alvarez N, Munoz-Murillo A, et al. Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables. PLoS One. 2014;9(9):e107625.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Choi I, Chung AW, Suscovich TJ, et al. Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees. PLoS Comput Biol. 2015;11(4):e1004185.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Pan Y, Liu H, Metsch LR, Feaster DJ. Factors associated with HIV testing among participants from substance use disorder treatment programs in the US: a machine learning approach. AIDS Behav. 2017;21(2):534–46.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Isabelle Guyon AE. An introduction to variable and feature selection. Mach Learn Res. 2003;3:25.

    Google Scholar 

  52. Muessig KE, Knudtson KA, Soni K, et al. “I didn’t tell you sooner because I didn’t know how to handle it myself”: developing a virtual reality program to support HIV-status disclosure decisions. Digit Cult Educ. 2018;10:22–48.

    PubMed  PubMed Central  Google Scholar 

  53. Oliveira A, Faria BM, Gaio AR, Reis LP. Data mining in HIV-AIDS surveillance system: application to Portuguese data. J Med Syst. 2017;41(4):51.

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest

The authors report no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Infectious Disease & International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

    Charurut Somboonwit & Lynette J. Menezes

  2. Harvard Medical School, Boston, MA, USA

    Lianet Vazquez

Authors
  1. Charurut Somboonwit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lianet Vazquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lynette J. Menezes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charurut Somboonwit .

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, University of South Florida, Tampa, FL, USA

    Paul Shapshak

  2. Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka, India

    Seetharaman Balaji

  3. Biomedical Informatics 17, Irulan Sandy Annex, Pondicherry, Pondicherry, India

    Pandjassarame Kangueane

  4. Oral Biology and Medicine, CHS 63-090, UCLA School of Dentistry Oral Biology and Medicine, CHS 63-090, Los Angeles, CA, USA

    Francesco Chiappelli

  5. Department of Internal Medicine, University of South Florida, Tampa, FL, USA

    Charurut Somboonwit

  6. Department of Internal Medicine, University of South Florida, Tampa, FL, USA

    Lynette J. Menezes

  7. Department of Internal Medicine, University of South Florida, Tampa, FL, USA

    John T. Sinnott

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Somboonwit, C., Vazquez, L., Menezes, L.J. (2019). HIV and Injection Drug Use: New Approaches to HIV Prevention. In: Shapshak, P., et al. Global Virology III: Virology in the 21st Century. Springer, Cham. https://doi.org/10.1007/978-3-030-29022-1_14

Download citation

Publish with us

Policies and ethics

Search

Navigation